Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema.
A Pressler, M Grosber, M Halle, J Ring, K Brockow
Index: Clin. Exp. Dermatol. 38(2) , 151-3, (2013)
Full Text: HTML
Abstract
Vibratory angio-oedema is a rare form of physical urticaria characterized by pruriginous weals and angio-oedema at the site of exposure to vibration. Severe treatment-resistant disease can occur, and is associated with significant disability. Therapy with omalizumab, a monoclonal IgG anti-IgE antibody, has been shown to be successful in several types of physical urticaria. We report a patient with vibratory angio-oedema for whom all standard treatments for urticaria, including omalizumab, failed to show a clinical benefit. Finally, ketotifen was tried, and unexpectedly reduced symptoms significantly. Ketotifen may thus represent a therapeutic option in patients with treatment-resistant vibratory angio-oedema.© The Author(s). CED © 2012 British Association of Dermatologists.
Related Compounds
Related Articles:
2015-03-01
[Biomed. Chromatogr. 29(3) , 465-74, (2015)]
2014-07-01
[Dtsch. Med. Wochenschr. 139(30) , 1523-34; quiz 1535-8, (2014)]
2012-01-01
[Biol. Pharm. Bull. 35(5) , 693-7, (2012)]
2014-08-01
[Pharm. Dev. Technol. 19(5) , 521-30, (2014)]
2011-10-01
[Mayo Clin. Proc. 86(10) , 1027, (2011)]